Abstract
Due to their biological importance, oligosaccharides and glycoconjugates have recently gained much attention. Investigations of such compounds often require chemically synthesized oligosaccharides. In the oligosaccharide synthesis, glycosylation reaction is frequently the most important step. Recently, one-pot multi-step glycosylations have become popular using the glycosyl donors with different reactivities and a polymer-supported technology that can reduce the laborious purification operations. For such methodologies, stereoselective glycosylation is essential. Compared to the 1,2-trans-glycoside formation, highly cis-selective glycosylation has remained relatively elusive. To enhance cis-selectivity, protection of the 2-position using a benzyl type ether and solvent effects are often employed. Recent reports have described the manipulation of protecting groups to afford novel donors that allow improved cisselective glycosylation. This manuscript reviews such donors that have been reported within the last five years. We hope this manuscript proves to be helpful in furthering the chemical syntheses of oligosaccharides while improving our understanding of the glycosylation reaction including stereoelectronic effects.
Keywords: Glycosylation reaction, stereoselectivity, protecting group
Current Bioactive Compounds
Title: Optimizing Glycosylation Reaction Selectivities by Protecting Group Manipulation
Volume: 4 Issue: 4
Author(s): Shino Manabe and Yukishige Ito
Affiliation:
Keywords: Glycosylation reaction, stereoselectivity, protecting group
Abstract: Due to their biological importance, oligosaccharides and glycoconjugates have recently gained much attention. Investigations of such compounds often require chemically synthesized oligosaccharides. In the oligosaccharide synthesis, glycosylation reaction is frequently the most important step. Recently, one-pot multi-step glycosylations have become popular using the glycosyl donors with different reactivities and a polymer-supported technology that can reduce the laborious purification operations. For such methodologies, stereoselective glycosylation is essential. Compared to the 1,2-trans-glycoside formation, highly cis-selective glycosylation has remained relatively elusive. To enhance cis-selectivity, protection of the 2-position using a benzyl type ether and solvent effects are often employed. Recent reports have described the manipulation of protecting groups to afford novel donors that allow improved cisselective glycosylation. This manuscript reviews such donors that have been reported within the last five years. We hope this manuscript proves to be helpful in furthering the chemical syntheses of oligosaccharides while improving our understanding of the glycosylation reaction including stereoelectronic effects.
Export Options
About this article
Cite this article as:
Manabe Shino and Ito Yukishige, Optimizing Glycosylation Reaction Selectivities by Protecting Group Manipulation, Current Bioactive Compounds 2008; 4 (4) . https://dx.doi.org/10.2174/157340708786847861
DOI https://dx.doi.org/10.2174/157340708786847861 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
3D QSAR Analysis of 2-(Substituted Aryl)-Thiazolidine-4-Carboxamides as Potent Antitubercular Agents
Current Computer-Aided Drug Design Computer Design of Vaccines: Approaches, Software Tools and Informational Resources
Current Computer-Aided Drug Design Analysis of Gene Logic Networks for Arabidopsis
Current Bioinformatics γ δ T Cells and Dendritic Cells: Close Partners and Biological Adjuvants for New Therapies
Current Molecular Medicine Nanocarriers Made from Non-Ionic Surfactants or Natural Polymers for Pulmonary Drug Delivery
Current Pharmaceutical Design Immune Restoration Disease: A Consequence of Dysregulated Immune Responses After HAART
Current HIV Research Carbohydrate based Potential Chemotherapeutic Agents: Recent Developments and their Scope in Future Drug Discovery
Mini-Reviews in Medicinal Chemistry Computer Aided Drug Design: Success and Limitations
Current Pharmaceutical Design Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations
Current Pharmacogenomics and Personalized Medicine Methylenetetrahydrofolate Reductase: Biochemical Characterization and Medical Significance
Current Pharmaceutical Design Preface:
Anti-Infective Agents A High-Throughput Assay for Developing Inhibitors of PhoP, a Virulence Factor of Mycobacterium tuberculosis
Combinatorial Chemistry & High Throughput Screening Strategically Placed Trifluoromethyl Substituent in the Realm of Antitubercular Drug Design
Current Drug Therapy Inflammatory Mediators as Potential Therapeutic Targets in the Spine
Current Drug Targets - Inflammation & Allergy Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study
Current Topics in Medicinal Chemistry Mucosal Delivery of Vaccines: Role of Mucoadhesive/Biodegradable Polymers
Recent Patents on Drug Delivery & Formulation State of the Art of Nanobiotechnology Applications in Neglected Diseases
Current Nanoscience Multi-Target-Directed Ligands as Innovative Tools to Combat Trypanosomatid Diseases
Current Topics in Medicinal Chemistry Current Developments in the Synthesis and Biological Activity of HIV-1 Double-Drug Inhibitors
Current Medicinal Chemistry Editorial (Hot Topic: Emerging Therapeutic Targets in Inflammation and Allergy Drug Discovery from Patent Perspective)
Recent Patents on Inflammation & Allergy Drug Discovery